We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.

AusPAR: Buprenorphine

Australian Public Assessment Report

AusPAR

AusPAR: Buprenorphine [PDF, 1.23 MB]

AusPAR: Buprenorphine [Word, 2.88 MB]

Attachment: Product Information Buprenorphine [PDF, 502.01 KB]

Attachment: Product Information Buprenorphine [Word, 624.61 KB]

Attachment: Product Information Buprenorphine 01 [PDF, 503.41 KB]

Attachment: Product Information Buprenorphine 01 [Word, 622.33 KB]

Device/Product Name

Buvidal

Active ingredients

Buprenorphine

AusPAR Date

6 November 2019

Published

18 November 2019

Submission Number

PM 2017-02926-1-1

Submission Type

Major variation (new dose form and new dose strengths)

Decision

Approved